SGLT2 inhibitors: from glucose-lowering to cardiovascular benefits. - Preda, Alberto; Montecucco, Fabrizio; Carbone, Federico; Camici, Giovanni G; Lüscher, Thomas F; Kraler, Simon; Liberale, Luca (Cardiovascular Research, 2024)